Matches in Nanopublications for { ?s ?p "[Loss of imprinting at insulin-like growth factor II (IGFII), in association with H19 silencing, has been described previously in a subgroup of Beckwith-Wiedemann syndrome (BWS) patients who have an elevated risk for Wilms' tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP208203.RAuoCCBgnHZTg3usUauJyvSjDsqaVKusY2a2brBTNHzEA130_assertion description "[Loss of imprinting at insulin-like growth factor II (IGFII), in association with H19 silencing, has been described previously in a subgroup of Beckwith-Wiedemann syndrome (BWS) patients who have an elevated risk for Wilms' tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208203.RAuoCCBgnHZTg3usUauJyvSjDsqaVKusY2a2brBTNHzEA130_provenance.
- assertion description "[Loss of imprinting at insulin-like growth factor II (IGFII), in association with H19 silencing, has been described previously in a subgroup of Beckwith-Wiedemann syndrome (BWS) patients who have an elevated risk for Wilms' tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP595987.RAQEY3UBzEj9r_Ldi_0a_GbHODO8KHf0ynlX6FCiSqSOE130_assertion description "[Loss of imprinting at insulin-like growth factor II (IGFII), in association with H19 silencing, has been described previously in a subgroup of Beckwith-Wiedemann syndrome (BWS) patients who have an elevated risk for Wilms' tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595987.RAQEY3UBzEj9r_Ldi_0a_GbHODO8KHf0ynlX6FCiSqSOE130_provenance.